SweeGen, a nature-based sweetener company announced today that its BESTEVIA® Reb D stevia leaf sweetener has successfully achieved the Non-GMO Project Verified status.
SweeGen’s unique production process starts with the stevia leaf and uses a proprietary technology to achieve high purity levels of Reb D. Sensory mapping, obtained through a trained sensory panel, shows that Reb D has a sugar-like taste and a sweetness onset and sweet linger (also called sweetness time intensity) that is closer to sugar than other stevia products. In 2017, the U.S. FDA issued the No Objection Letter for BESTEVIA® Reb D stevia leaf sweetener for use as a general-purpose, non-nutritive sweetener for foods and beverages (GRN No. 715).
“Both our BESTEVIA® Reb M and Reb D stevia leaf sweeteners are now certified Non-GMO, which gives them a great distinction on the market. As consumer demand for sugar reduction and non-GMO products grows, this is another big milestone for us and our customers,” said Katharina Pueller, SweeGen’s director of natural sweetener business.
The Non-GMO Project (www.nongmoproject.org) offers independent verification for products made according to rigorous best practices for GMO (genetically modified organisms) avoidance. Verified products are produced in compliance with the Non-GMO Project Standard.
SweeGen (OTC: SWEE) is dedicated to the development, production and distribution of non-caloric sweeteners for the food, beverage and flavor industries. SweeGen’s robust product pipeline, intellectual property portfolio, dedicated manufacturing capacity and R&D provide the Company its foundation for innovation and delivery of high-quality sweeteners. For more information, please contact email@example.com or visit SweeGen’s website www.sweegen.com.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains forward-looking statements including statements regarding the future outlook and performance of SweeGen, Inc., and other statements based on current management expectations, estimates and projections. These statements are subject to a variety of risks and uncertainties, are not guarantees and are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. These risks and uncertainties include, without limitation, those that may be discussed from time to time in the company’s filings with the Securities and Exchange Commission. The forward-looking statements included in this news release are only made as of the date of this release, and SweeGen, Inc. disclaims any obligation to publicly update any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.